Www.huntingdon.com www.harlan.com Fiona McGuinness 29 April 2015 Harmonising Formulation Analysis Procedures.

Slides:



Advertisements
Similar presentations
Bioavailability Bioavailability means the rate and extent to which the active substance is adsorbed from a pharmaceutical product and become available.
Advertisements

Quality is a Lousy Idea-
Tests of Hypotheses Based on a Single Sample
Dr. Birgit Schmauser, BfArM, Bonn
Analytical Method Development and Validation
DBS – Process & Review GHANSHYAM. 3Rs No need to explain…………… GOAL IS ANIMAL SAVING R1 REPLACEMENT R2 REFINEMENT R3 REDUCTION.
World Health Organization
Statistical Comparison of Two Learning Algorithms Presented by: Payam Refaeilzadeh.
Quality Assurance/Quality Control Policy
Introduction into the workshop Drs. Jan Welink Training workshop: Training of BE assessors, Kiev, October 2009.
WLTP Phase 1B Main Open Issues Road and Dyno Load Presentation at WLTP IG Meeting Geneva Open Issues Road and Dyno Load- K. Kolesa Working paper.
ASEAN GUIDELINES FOR VALIDATION OF ANALYTICAL PROCEDURES
QUALITY CONTROL OF PHYSICO-Chemical METHODS Introduction :Validation توثيق المصدوقية.
Kyiv, TRAINING WORKSHOP ON PHARMACEUTICAL QUALITY, GOOD MANUFACTURING PRACTICE & BIOEQUIVALENCE Validation of Analytical Methods Used For Bioequivalence.
Chemometrics Method comparison
Quality Control In Measurements Tom Colella CLAS Goldwater Environmental Lab.
Validation of Analytical Method
Laboratory Validation of Analytical Methods
AICT5 – eProject Project Planning for ICT. Process Centre receives Scenario Group Work Scenario on website in October Assessment Window Individual Work.
MultiSimplex and experimental design as chemometric tools to optimize a SPE-HPLC-UV method for the determination of eprosartan in human plasma samples.
The following minimum specified ranges should be considered: Drug substance or a finished (drug) product 80 to 120 % of the test concentration Content.
Quantitative Chemical Analysis Seventh Edition Quantitative Chemical Analysis Seventh Edition Chapter 0 The Analytical Process Copyright © 2007 by W. H.
Analytical considerations
Unit 1 Accuracy & Precision.  Data (Singular: datum or “a data point”): The information collected in an experiment. Can be numbers (quantitative) or.
Quality WHAT IS QUALITY
HPLC Pigment Processing Update Crystal Thomas Science Systems and Applications, Inc. (SSAI) NASA-Goddard Space Flight Center 23April2012 NASA OCRT meeting.
Quality Control – Part II Tim Hanley EPA Office of Air Quality Planning and Standards.
Quality Assurance How do you know your results are correct? How confident are you?
5. Quality Assurance and Calibration Quality assurance is We do to get the right answer for our purpose. Have Sufficient accuracy and precision to support.
Protocol for inter-laboratory calibration of Male’s monitoring network Nguyen Thi Kim Oanh EEM/SERD, AIT Male’ Declaration 4 th Regional Stakeholders-cum-
1 Is it potent? Can these results tell me? Statistics for assays Ann Yellowlees PhD Quantics Consulting Limited.
1 Exercise 7: Accuracy and precision. 2 Origin of the error : Accuracy and precision Systematic (not random) –bias –impossible to be corrected  accuracy.
Rachel Martin Displacement and Density. Introduction Animals are dosed by being given a specific volume of a test item (or control) formulation.
Investigating Out of Specification Results
The Value of Digital Photography By Louise Rutherford and Dean Hatt.
Validation Defination Establishing documentary evidence which provides a high degree of assurance that specification process will consistently produce.
Trials and Tribulations of Developing a Method for Quantification of Aerosol Chamber Concentration Richard Snell, Dose Concentration Analysis GSK.
Stability Indicating Assays for Dose Formulation Stability Testing Teresa Fuller GSK.
Malaysia, EVALUTION OF DOSSIERS IN WHO- PREQUALIFICATION PROJECT MULTISOURCE TB-DRUGS Evaluation of bioavailability/bioequivalence data Based,
HPLC Pigment Analysis at HPL Crystal S. Thomas Laurie Van Heukelem VIIRS/MODIS Science Team Meeting May 14, 2008.
Industrial Technology Institute Test Method Validation & Verification H.P.P.S.Somasiri Principal Research Scientist / SDD-QAD /QM Industrial Technology.
LECTURE 13 QUALITY ASSURANCE METHOD VALIDATION
Topic: Pitch Extraction
WLTP ANNEX 4, ROAD LOAD CALCULATION Proposal for calculating the road load of individual vehicles C. Lueginger, BMW; A. Feucht, Audi WLTP-DTP-LabProcICE-202.
1 AMPS 4 22/ Brussels Discussion Paper As of , Bullet 4 Analytical Methods for Operational and Surveillance Monitoring Of WFD PS.
 Routine viral diagnostics: indirect and direct detection of viruses. ◦ Indirect detection: serological tests; ◦ Direct detection:  Viral antigens;
Lecture 10 ANALYTICAL METHOD DEVELOPMENT AND VALIDATION IN HPLC AND GC. Lecture 10 – Chromatography, Dr. Rasha Hanafi 1© Dr. Rasha Hanafi, GUC.
SEMINAR ON PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
EQUIPMENT and METHOD VALIDATION
means to “TO CHECK OR PROVE THE VALIDITY OF” According to FDA – “ The goal of validation is to establish a documented evidence which provides a high degree.
이 장 우. 1. Introduction  HPLC-MS/MS methodology achieved its preferred status -Highly selective and effectively eliminated interference -Without.
Plasma Free Metanephrines Analysis using LC-MS/MS with Porous Graphitic Carbon Column Xiang He (Kevin) and Marta Kozak Thermo Fisher Scientific.
Multi-Analyte LC-MS/MS Methods – Best Practice.
Quality is a Lousy Idea-
World Health Organization
USE OF ENGLISH EXAM PAPERS.
Dr. Birgit Schmauser, BfArM, Bonn
Analytical considerations
STANDARD DEVIATION.
International Journal of Pharmaceutics 327 (2006) 12–16
Janice L. Willey Senior Chemist
Quality is a Lousy Idea-
Analytical Method Validation
WLTP DTP PM-PN Subgroup Activities, Progress & Future Plans
World Health Organization
Introduction To Medical Technology
DICLOFENAC Validation according to requirements
AEROSET® & ARCHITECT® c8000® OEM Reagent Training
AEROSET® & ARCHITECT® c8000® OEM Reagent Training
Presentation transcript:

Fiona McGuinness 29 April 2015 Harmonising Formulation Analysis Procedures

Introduction  What is best practice?  Why harmonise?  What will be harmonised?  Harmonisation process  Discussion

Best Practice?  3 sites doing 3 separate procedures  White paper?  What parameters and acceptance criteria examined?

Why Harmonise?  One company, one process  Opportunity to look at processes and make changes or improvements  Discuss experiences to decide which way is the best way

What will be harmonised?  Parameters examined: Validation Sampling of diet formulations for stability assessment Homogeneity assessment Stability trial formulation size Standard and extract stability Pre-dose analysis Number of samples for routine analysis Genetic toxicology support

Method Accuracy and Precision  Site 1: 6 replicates of lowest and highest concentrations  Site 2: 3 replicates at lowest, intermediate and highest concentrations  Site 3: 2 replicates at lowest, intermediate and highest concentrations

Harmonised Approach  5 replicates at each lowest and highest levels

Diet Stability Trials  Site 1 Samples taken immediately after preparation into bags and stored ambient and frozen for specified time-points  Site 2 In drum, at ambient storage. Samples taken from drum at specified time-points  Site 3 Sample taken in glass jar and stored at ambient for 21 days

Proposed Change  Samples from drum at each time-point  Frozen sample taken on Day 0 and stored for 22 days (or more if time allows)

Not yet… working towards  Pre-dose analysis

Standard and Extract Stability  Site 1: Assessed, at least 4 days to allow re-analysis if necessary  Site 2: Not routinely done  Site 3: Not routinely done

Other validation parameters ParameterSite 1Site 2Site 3 LOD/LOQEstimated 3x BN and 10x BN Not calculated SpecificityControl vehicle extracted and examined for peaks LinearityAt least 5 standards over a 10-fold range R 2 ≥0.999 Back-fits within 10% At least 5 standards no fixed range R 2 ≥0.999 Back-fits within 20% At least 5 standards no fixed range R 2 ≥no criteria Back-fits no criteria System Precision6 injections of lowest and highest standards CV≤2% 6 injections of mid- concentration standard CV≤2% Not routinely done

How do you decide?  Highlight similarities?

Other validation parameters ParameterSite 1Site 2Site 3 LOD/LOQEstimated 3x BN and 10x BN Not calculated SpecificityControl vehicle extracted and examined for peaks LinearityAt least 5 standards over a 10-fold range R 2 ≥0.995 Back-fits within 10% At least 5 standards no fixed range R 2 ≥0.995 Back-fits within 20% At least 5 standards no fixed range R 2 ≥no criteria Back-fits no criteria System Precision6 injections of lowest and highest standards CV≤2% 6 injections of mid- concentration standard CV≤2% Not routinely done

Calibration Standard Acceptance  Over to you…..

 Any questions or further discussion points??